These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25738038)

  • 1. Is It Safe to Provide Abortion Pills over the Counter? A Study on Outcome Following Self-Medication with Abortion Pills.
    Nivedita K; Shanthini F
    J Clin Diagn Res; 2015 Jan; 9(1):QC01-4. PubMed ID: 25738038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Complications and Management After Self-Administration of Medical Termination of Pregnancy Pills.
    Rath S; Mishra S; Tripathy R; Dash S; Panda B
    Cureus; 2021 Nov; 13(11):e19730. PubMed ID: 34934592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-the-counter MTP Pills and Its Impact on Women's Health.
    Sarojini ; Ashakiran TR; Bhanu BT; Radhika
    J Obstet Gynaecol India; 2017 Feb; 67(1):37-41. PubMed ID: 28242966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Self Induced Abortion by Self-Administration of Abortive Pills among Abortion-related Admissions in a Tertiary Care Centre.
    Thapa B; Sharma N; Dwa YP
    JNMA J Nepal Med Assoc; 2020 Dec; 58(232):971-975. PubMed ID: 34506389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Unsupervised Medical Termination of Pregnancy Pill Usage Among Women: A Cross-Sectional Study From North India.
    Pal R; Gupta PK; Tyagi S; Palariya H; Vora V; Agarwal P
    Cureus; 2023 Nov; 15(11):e49321. PubMed ID: 38143596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost.
    Bartley J; Tong S; Everington D; Baird DT
    Contraception; 2000 Dec; 62(6):297-303. PubMed ID: 11239616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abortion admissions in rural Matebeleland north province.
    Rutgers S
    Cent Afr J Med; 2001; 47(9-10):214-20. PubMed ID: 12808770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the October 1995 pill scare in Grampian.
    Flett G; Gurney E; McKessock L; Reid J
    Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Unsafe Abortion: Patterns and Outcomes in a Tertiary Level Hospital.
    Shamsi S; Mirza TT; Shejuti TR; Nigar K; Nahar S; Begum S; Sharmin T; Panna LK; Islam N; Jahan T
    Mymensingh Med J; 2020 Jul; 29(3):523-529. PubMed ID: 32844789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconceptualizing safe abortion and abortion services in the age of abortion pills: A discussion paper.
    Berer M
    Best Pract Res Clin Obstet Gynaecol; 2020 Feb; 63():45-55. PubMed ID: 31494046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting.
    Acharya G; Haugen M; Bråthen A; Nilsen I; Maltau JM
    Acta Obstet Gynecol Scand; 2004 Apr; 83(4):390-4. PubMed ID: 15005788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety.
    Larsson A; Ronnberg AM
    Acta Obstet Gynecol Scand; 2019 Jun; 98(6):747-752. PubMed ID: 30659579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of Edinburgh.
    Cameron ST; Glasier AF; Logan J; Benton L; Baird DT
    Br J Obstet Gynaecol; 1996 Dec; 103(12):1222-9. PubMed ID: 8968240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of hospital vs home self administration of vaginal misoprostol for medical abortion.
    Shrestha A; Sedhai LB
    Kathmandu Univ Med J (KUMJ); 2014; 12(47):185-9. PubMed ID: 25855109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of abortion complications at a rural hospital in Uganda: a quality assessment by a partially completed criterion-based audit.
    Mellerup N; Sørensen BL; Kuriigamba GK; Rudnicki M
    BMC Womens Health; 2015 Sep; 15():76. PubMed ID: 26388296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early complications after induced first-trimester abortion.
    Heisterberg L; Kringelbach M
    Acta Obstet Gynecol Scand; 1987; 66(3):201-4. PubMed ID: 3661126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illegal induced abortion: a study of 74 cases in Ile-Ife, Nigeria.
    Okonofua FE; Onwudiegwu U; Odunsi OA
    Trop Doct; 1992 Apr; 22(2):75-8. PubMed ID: 1604719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early pregnancy termination with a simplified mifepristone: Medical abortion outpatient regimen.
    Chuni N; Chandrashekhar TS
    Kathmandu Univ Med J (KUMJ); 2009; 7(27):209-12. PubMed ID: 20071864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further acceptability evaluation of RU486 and ONO 802 as abortifacient agents in a Chinese population.
    Tang GW; Lau OW; Yip P
    Contraception; 1993 Sep; 48(3):267-76. PubMed ID: 8222656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal mortality and morbidity associated with clandestine abortions.
    Sood M; Juneja Y; Goyal U
    J Indian Med Assoc; 1995 Feb; 93(2):77-9. PubMed ID: 7658045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.